|
Orthologous residues
|
|
ACLY (human): S455‑p, ACLY iso3 (human): S65‑p, ACLY (mouse): S455‑p, ACLY iso2 (mouse): S455‑p, ACLY iso3 (mouse): S455‑p, ACLY (rat): S454‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, peptide sequencing, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
hepatocyte-liver
|
|
Cellular systems studied:
primary cultured cells
|
|
Species studied:
rat
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
insulin
|
|
|
|
increase
|
|
|
|
|